Tau Publications
-
(2011)
Acker, C.M., Forest, S.K., Zinkowski, R., Davies, P., d’Abramco, C.
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.
Neurobiology of Aging; Volume 33, Issue 8, Pages 1493-1856 (August 2012) DOI 10.1016/j.neurobiolaging.2012.05.010.
-
(2011)
Nitsch, R, Chen, F , Grimm, J , Baeriswyl, J , Hock, C.
. United States Patent Application 20120087861;; 2012 Apr 12; DOI: y2012/0087861.html.
Human Anti-Tau Antibodies.
-
(2011)
Madampage, C., Tavassoly, O., Christensen, C., Kumari, M., Lee, J.S.
Nanopore Analysis: An emerging technique for studying the folding and misfolding of proteins.
Prion; 2012 Apr 1;6(2):116-23. Epub 2012 Apr 1.pp 116-123 DOI /10.4161/pri.18665.
-
(2011)
Nakamura, K., Greenwood, A., Binder, L., Bigio, EH, Denial, S, Nicholson, L., Zhou, XZ, Lu, KP
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease.
Cell; Volume 149, Issue 1, 232-244, 2012 March 30 DOI: 10.1016/j.cell.2012.02.016.
-
(2011)
Saman, S., Kim, W, Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, AC, Alvarez, VE, Lee, NC and Hall, GF.
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease.
The Journal of Biological Chemistry; 2012 Feb 3; The Journal of Biological Chemistry, 287, 3842-3849. doi: 10.1074/jbc.M111.277061.
-
(2011)
Wilhelmus, M. M., de Jager, M., Rozemuller, A. J., Brevé, J., Bol, J. G., Eckert, R. L. and Drukarch, B.,
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.
-
(2010)
Chai, X., Wu, S., Murray, T., Kinley, R, Cella, C., Sims, H., Buckner, N., Hanmer, J., Davies, P., O'Neill, M, .Hutton, M.and Citron, M.
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models.
The Journal of Biological Chemistry; 2011 Sept 30 The Journal of Biological Chemistry, 286, 34457-34467.2011 Aug 12, doi: 10.1074/jbc.M111.229633.
-
(2010)
Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, Ward S, Reyes JF, Philibert K, Glucksman MJ, Binder LI.
Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.
J Biol Chem; 2011 Jul 1;286(26):23063-76. Epub 2011 May 6; PMID: 21550980; PMCID: PMC3123074.
-
(2010)
Snow, A. , Hu, Q., Lake, T.
Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies
. United States Patent Application; United States Patent Application 20110144124; 2011 June 16; DOI: y2011/0144124.html.
-
(2009)
Barten, D.M, Cadelina, G.W., Hoque, N., DeCarr, L.B., Guss, V. L., Yang, L., Sankaranarayanan, S., Wes, P.D., Flynn, M. E., Meredith, J, Ahlijanian, M., Albright, C.
Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers.
Journal of Alzheimer’s Disease; Volume 24, Supplement 2/ 2011 Mar 18 DOI: 10.3233/JAD-2011-110161.
